Plus Therapeutics (PSTV) Misses Q2 EPS by 71c

Plus Therapeutics (NASDAQ: PSTV) reported Q2 EPS of ($0.71). Revenue for the quarter came in at $1.27 million.

For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.

You May Also Be Interested In

• Goldman Sachs Starts Excelerate Energy Inc (EE) at Buy
• Citizens launches transportation coverage, names FedEx a top large-cap pick
• Us To Impose 25% Tariff On Some Brazilian Goods From July 22 - Bloomberg